gw pharmaceuticals plc united kingdom based gw pharmaceuticals plc reported a wider net loss and said it plans to start human trials of an experimental treatment for obesity derived from cannabis cannabis is commonly associated with stimulating hunger and several other companies such as sanofi aventis with its drug acomplia are working on new drugs that try to switch off the brain circuits that make people hungry when they smoke it gw pharma says it derived a treatment from cannabis that could help suppress hunger the companys net loss widened to gbp million &# million in the year ended sept from a loss of gbp million a year earlier sales dropped to gbp million from gbp million the previous year when the company received a milestone payment from marketing partner bayer ag 
